ArticleFrontiers in immunology2022

Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.

Cuijian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.